ValuEngine Lowers Humana Inc. (HUM) to Hold
ValuEngine downgraded shares of Humana Inc. (NYSE:HUM) from a buy rating to a hold rating in a report published on Tuesday morning.
Several other analysts have also commented on the company. Citigroup Inc. initiated coverage on Humana in a report on Wednesday, June 28th. They set a buy rating and a $275.00 price objective for the company. BidaskClub lowered Humana from a buy rating to a hold rating in a report on Wednesday, July 19th. Bank of America Corporation increased their price objective on Humana from $270.00 to $275.00 and gave the company a buy rating in a report on Friday, July 14th. Piper Jaffray Companies increased their price objective on Humana to $280.00 and gave the company an overweight rating in a report on Thursday, August 3rd. Finally, Zacks Investment Research lowered Humana from a buy rating to a hold rating in a report on Tuesday, July 18th. Eleven research analysts have rated the stock with a hold rating and twelve have given a buy rating to the stock. The stock presently has a consensus rating of Buy and an average target price of $251.60.
Humana (HUM) opened at 237.73 on Tuesday. Humana has a 1-year low of $165.03 and a 1-year high of $259.76. The stock has a 50 day moving average price of $247.57 and a 200 day moving average price of $235.40. The stock has a market cap of $34.36 billion, a PE ratio of 19.56 and a beta of 0.86.
Humana (NYSE:HUM) last issued its quarterly earnings data on Wednesday, August 2nd. The insurance provider reported $3.49 EPS for the quarter, beating the consensus estimate of $3.08 by $0.41. Humana had a return on equity of 15.85% and a net margin of 3.37%. The firm had revenue of $13.53 billion during the quarter, compared to analyst estimates of $13.61 billion. During the same quarter in the prior year, the business posted $2.30 EPS. On average, analysts predict that Humana will post $11.56 EPS for the current fiscal year.
The business also recently declared a dividend, which will be paid on Monday, October 16th. Shareholders of record on Friday, September 29th will be given a dividend of $0.40 per share. The ex-dividend date of this dividend is Thursday, September 28th. Humana’s dividend payout ratio is currently 13.06%.
In other Humana news, insider William Kevin Fleming sold 3,071 shares of the stock in a transaction dated Wednesday, August 23rd. The stock was sold at an average price of $250.98, for a total transaction of $770,759.58. Following the sale, the insider now directly owns 7,681 shares of the company’s stock, valued at approximately $1,927,777.38. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Bruce D. Broussard sold 12,000 shares of the stock in a transaction dated Friday, August 11th. The stock was sold at an average price of $251.88, for a total value of $3,022,560.00. Following the sale, the chief executive officer now directly owns 80,086 shares in the company, valued at $20,172,061.68. The disclosure for this sale can be found here. Insiders have sold a total of 55,595 shares of company stock worth $14,133,706 over the last ninety days. 0.80% of the stock is owned by insiders.
A number of institutional investors and hedge funds have recently made changes to their positions in the business. Guardian Life Insurance Co. of America grew its position in Humana by 0.7% during the 1st quarter. Guardian Life Insurance Co. of America now owns 575 shares of the insurance provider’s stock worth $119,000 after purchasing an additional 4 shares during the period. Reliance Trust Co. of Delaware grew its position in Humana by 0.7% during the 2nd quarter. Reliance Trust Co. of Delaware now owns 1,123 shares of the insurance provider’s stock worth $270,000 after purchasing an additional 8 shares during the period. Creative Planning grew its position in Humana by 0.3% during the 2nd quarter. Creative Planning now owns 4,874 shares of the insurance provider’s stock worth $1,173,000 after purchasing an additional 15 shares during the period. WFG Advisors LP grew its position in Humana by 4.5% during the 2nd quarter. WFG Advisors LP now owns 469 shares of the insurance provider’s stock worth $113,000 after purchasing an additional 20 shares during the period. Finally, Cadence Capital Management LLC grew its position in Humana by 0.4% during the 2nd quarter. Cadence Capital Management LLC now owns 5,682 shares of the insurance provider’s stock worth $1,367,000 after purchasing an additional 22 shares during the period. 95.12% of the stock is currently owned by institutional investors.
Humana Inc is a health and well-being company. The Company’s segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for Humana Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.